Published in Arthritis Rheum on December 17, 1974
Reactive arthritis associated with Campylobacter jejuni enteritis. Br Med J (1979) 2.46
Role of Chlamydia trachomatis and HLA-B27 in sexually acquired reactive arthritis. Br Med J (1978) 2.01
Progress report. Familial inflammatory bowel disease--heredity or environment? Gut (1976) 1.81
HLA-B27 and the immune response to enterobacterial antigens in ankylosing spondylitis. Clin Exp Immunol (1984) 1.79
Evidence of Chlamydia trachomatis infection in sexually acquired reactive arthritis. Ann Rheum Dis (1980) 1.65
Histopathology of intestinal inflammation related to reactive arthritis. Gut (1987) 1.64
Possible role of enteric organisms in the pathogenesis of ankylosing spondylitis and other seronegative arthropathies. Infect Immun (1983) 1.57
Inherited susceptibility to rheumatic disease. J R Soc Med (1978) 1.54
Virulence-plasmid is associated with the inhibition of opsonization in Yersinia enterocolitica and Yersinia pseudotuberculosis. Clin Exp Immunol (1987) 1.36
IgA-anti-yersinia antibodies in yersinia triggered reactive arthritis. Ann Rheum Dis (1986) 1.35
HLA-B27 antigen in diagnosis of atypical seronegative inflammatory arthropathy. Ann Rheum Dis (1976) 1.32
Mycoplasma pneumoniae infection and arthritis in man. Br Med J (1977) 1.15
Postdiarrheal arthropathy of Yersinia pseudotuberculosis. Can Med Assoc J (1978) 1.15
Treatment of non-steroidal anti-inflammatory drug induced enteropathy. Gut (1990) 1.14
Arthritogenicity of genetically manipulated Yersinia enterocolitica serotype O8 for Lewis rats. Infect Immun (1995) 1.02
Acute anterior uveitis after yersinia infection. Br J Ophthalmol (1982) 1.01
Persistence of HLA-B27 cross-reactive bacteria in bowel flora of patients with ankylosing spondylitis. Infect Immun (1984) 1.01
HLA frequencies in less common arthropathies. Ann Rheum Dis (1976) 0.99
Arthritis and neuralgic amyotrophy due to Yersinia enterocolitica. Br Med J (1979) 0.97
Yersinia-induced uveitis in Ireland. Br J Ophthalmol (1988) 0.94
Microarray analysis of response of Salmonella during infection of HLA-B27- transfected human macrophage-like U937 cells. BMC Genomics (2010) 0.93
Yersinia enterocolitica serotype O:3 alters the expression of serologic HLA-B27 epitopes on human monocytes. Infect Immun (1997) 0.92
Significance of non-pathogenic cross reactive bowel flora in patients with ankylosing spondylitis. Ann Rheum Dis (1986) 0.91
B27 positive diseases versus B27 negative diseases. Ann Rheum Dis (1988) 0.90
Depressed lymphocyte transformation by yersinia and Escherichia coli in yersinia arthritis. Ann Rheum Dis (1983) 0.90
Seronegative arthropathies. J R Soc Med (1983) 0.89
Post-yersinial arthritis in Cleveland, England. Ann Rheum Dis (1989) 0.87
When is arthritis reactive? Postgrad Med J (2006) 0.87
Avidity of antibodies against released proteins of Yersinia spp: comparison of patients with or without reactive arthritis. Ann Rheum Dis (1989) 0.87
Aetiology and pathogenesis of reactive arthritis: role of non-antigen-presenting effects of HLA-B27. Arthritis Res Ther (2005) 0.85
Synovial fluid cells in Reiter's syndrome. Ann Rheum Dis (1985) 0.82
Antibody producing capacity to the bacteriophage phi X174 in yersinia arthritis. Ann Rheum Dis (1987) 0.81
Long term prognosis in yersinia arthritis: clinical and serological findings. Ann Rheum Dis (1992) 0.81
Late complications after a Yersinia enterocolitica epidemic: a follow up study. Ann Rheum Dis (1991) 0.80
Frequency of HLA-B27 and its alleles in patients with Reiter syndrome: comparison with the frequency in other spondyloarthropathies and a healthy control population. Rheumatol Int (2007) 0.80
Cytotoxic T-cell-mediated response against Yersinia pseudotuberculosis in HLA-B27 transgenic rat. Infect Immun (1999) 0.79
Post-Yersinia Arthritis. West J Med (1980) 0.79
Arthritis in the highlands of Papua New Guinea. Ann Rheum Dis (1993) 0.78
Reactive arthritis following Yersinia pseudotuberculosis infection. Ulster Med J (1990) 0.78
Serum opsonic capacity against Yersinia enterocolitica O:3 in yersiniosis patients with or without reactive arthritis. Clin Exp Immunol (1989) 0.78
HLA-B27 associated spondyloarthropathy, an autoimmune disease based on crossreactivity between bacteria and HLA-B27? Ann Rheum Dis (1999) 0.78
The relationship between genetics and environment in the pathogenesis of rheumatic diseases. West J Med (1979) 0.77
Various rheumatic syndromes in adult patients associated with high antistreptolysin O titres and their differential diagnosis with rheumatic fever. Ann Rheum Dis (1993) 0.77
Ultrahistopathology of balanitis circinata. Br J Vener Dis (1982) 0.76
Complement activation and HLA-B27. Ann Rheum Dis (1988) 0.76
Expression of HLA-B27 antigens on mononuclear leucocytes in ankylosing spondylitis. Clin Exp Immunol (1985) 0.76
Editorial: Polyarthritis and Yersinia enterocolitica infection. Br Med J (1975) 0.75
Yersinia enterocolitica endocarditis on a prosthetic valve. Postgrad Med J (1992) 0.75
Postdysenteric Reiter's syndrome. West J Med (1977) 0.75
Muramic acid is not generally present in the human spleen as determined by gas chromatography-tandem mass spectrometry. Infect Immun (2002) 0.75
Polyarteritis associated with Yersinia enterocolitica infection. Ann Rheum Dis (1992) 0.75
THE SOURCE OF INFECTION AND THE MOST FREQUENT CAUSES OF REACTIVE ARTHRITIS IN KOSOVO. Mater Sociomed (2016) 0.75
HLA system and rheumatic disease. J Clin Pathol Suppl (R Coll Pathol) (1978) 0.75
Modes of presentation of reactive arthritis based on the affected joints. Med Arch (2015) 0.75
Rheumatic disease-a case of the soil and the seed. West J Med (1979) 0.75
Association between high antistaphylolysin and teichoic acid antibody titres with rheumatic syndromes. Clin Rheumatol (1997) 0.75
Characterizing the quantitative genetic contribution to rheumatoid arthritis using data from twins. Arthritis Rheum (2000) 6.88
Cerebrovascular disease in the community: results of a WHO collaborative study. Bull World Health Organ (1980) 5.66
Arthritis associated with Yersinia enterocolitica infection. Acta Rheumatol Scand (1969) 4.03
A simple micro cytotoxicity test. Transplantation (1969) 3.67
Smoking and risk of rheumatoid arthritis. J Rheumatol (1993) 3.63
Clinical efficacy of meningococcus group A capsular polysaccharide vaccine in children three months to five years of age. N Engl J Med (1977) 3.32
Prediction of myocardial infarction in dyslipidemic men by elevated levels of immunoglobulin classes A, E, and G, but not M. Arch Intern Med (1998) 3.01
Prevalence, determinants, and consequences of chronic neck pain in Finland. Am J Epidemiol (1991) 2.59
Marked cross-agglutination between Brucellae and a subtype of Yersinia enterocolitica. Acta Pathol Microbiol Scand (1969) 2.57
Persistence of IgM, IgG, and IgA antibodies to Yersinia in yersinia arthritis. J Infect Dis (1980) 2.45
Human yersiniosis in Finland. I. Bacteriology and serology. Ann Clin Res (1972) 2.28
Increased incidence of alcohol-related deaths from accidents and violence in subjects with ankylosing spondylitis. Br J Rheumatol (1998) 2.28
Studies of syphilitic antibodies. I. Anti-lipoidal antibodies in various stages of syphilis. Br J Vener Dis (1967) 2.07
HL-A antigen 27 and reactive arthritis. Lancet (1973) 2.07
Human yersiniosis in Finland. II. Clinical features. Ann Clin Res (1972) 2.07
Cardiovascular mortality in women with rheumatoid arthritis. J Rheumatol (1995) 1.96
Immunopathology of rheumatoid arthritis. Antikeratin antibodies precede the clinical disease. Arthritis Rheum (1992) 1.90
Occurrence of rheumatoid arthritis in a nationwide series of twins. J Rheumatol (1986) 1.88
Yersinia enterocolitica as a cause of acute mesenteric lymphadenitis. Acta Paediatr Scand (1968) 1.88
Psoriasis and HLA-Cw6. Br J Dermatol (1980) 1.83
Studies on T-strain mycoplasmas in nongonococcal urethritis. Br J Vener Dis (1971) 1.79
Essential tremor in a Finnish population. Acta Neurol Scand (1982) 1.78
Worldwide ethnic distribution of the G protein beta3 subunit 825T allele and its association with obesity in Caucasian, Chinese, and Black African individuals. J Am Soc Nephrol (1999) 1.76
Coffee consumption, rheumatoid factor, and the risk of rheumatoid arthritis. Ann Rheum Dis (2000) 1.74
Frequent association of chlamydial infection with Reiter's syndrome. Sex Transm Dis (1999) 1.72
Chlamydia trachomatis in acute salpingitis. Br J Vener Dis (1979) 1.69
Death attributed to antirheumatic medication in a nationwide series of 1666 patients with rheumatoid arthritis who have died. J Rheumatol (1995) 1.66
The treatment of gonorrhoea with doxycycline as a single dose. Chemotherapy (1968) 1.56
Rheumatic symptoms in the middle-aged population in southwestern Finland. Scand J Rheumatol Suppl (1982) 1.55
Amyloidosis in a nationwide series of 1666 subjects with rheumatoid arthritis who died during 1989 in Finland. Rheumatology (Oxford) (1999) 1.53
Joint symptoms and diseases associated with moisture damage in a health center. Clin Rheumatol (2003) 1.51
When does rheumatoid disease start? Arthritis Rheum (1985) 1.50
Smoking, lung function, and rheumatoid factors. Ann Rheum Dis (1990) 1.43
Work disability in an inception cohort of patients with seropositive rheumatoid arthritis: a 20 year study. Rheumatology (Oxford) (1999) 1.43
Validity of hospital discharge data in a prospective epidemiological study on stroke and myocardial infarction. Acta Med Scand (1984) 1.43
Circinate erosive balanitis and HL-A 27. Acta Derm Venereol (1975) 1.42
Anticardiolipin response in acute infections. Clin Immunol Immunopathol (1986) 1.39
Lumbar disc syndrome in Finland. J Epidemiol Community Health (1987) 1.38
Mortality from cancer in patients with rheumatoid arthritis. Scand J Rheumatol (1995) 1.37
Development of rheumatoid factor activity and cryoglobulins in primary and secondary syphilis. Int Arch Allergy Appl Immunol (1969) 1.37
Histocompatibility (HL-A) antigens associated with myasthenia gravis. A preliminary report. Ann Clin Res (1972) 1.37
Examination of men with nongonococcal urethritis and their sexual partners for Chlamydia trachomatis and Ureaplasma urealyticum. Sex Transm Dis (1979) 1.36
Ocular inflammation in Reiter's disease after Salmonella enteritis. Am J Ophthalmol (1980) 1.35
Crossreaction between antibodies to oxidised low-density lipoprotein and to cardiolipin in systemic lupus erythematosus. Lancet (1993) 1.34
Fetal leukocytes in the maternal circulation after delivery. I. Cytological aspects. Transplantation (1974) 1.34
Familial occurrence of Yersinia enterocolitica infection and acute arthritis. Acta Paediatr Scand Suppl (1970) 1.32
Association of different HLA antigens with various toxic effects of gold salts in rheumatoid arthritis. Ann Rheum Dis (1986) 1.32
Fuchs' heterochromic cyclitis associated with retinitis pigmentosa: a family study. Can J Ophthalmol (1979) 1.29
Occurrence of uveitis in recently diagnosed juvenile chronic arthritis: a prospective study. Ophthalmology (2001) 1.28
Rheumatoid factor, chronic arthritis and mortality. Ann Rheum Dis (1995) 1.26
Mortality in rheumatoid arthritis. Semin Arthritis Rheum (1995) 1.26
Serum antioxidants and risk of rheumatoid arthritis. Ann Rheum Dis (1994) 1.24
Shift in the incidence of rheumatoid arthritis toward elderly patients in Finland during 1975-1990. Clin Exp Rheumatol (1997) 1.24
Experimentally induced mononucleosis-like heterophile antibodies in man. Clin Exp Immunol (1969) 1.22
Chemotaxis in yersinia arthritis. HLA-B27 positive neutrophils show high stimulated motility in vitro. Arthritis Rheum (1980) 1.21
Doxycycline treatment of nongonococcal urethritis with special reference to T-strain mycoplasmas. Br J Vener Dis (1971) 1.21
Polyarthritis associated with Yersinia enterocolitica infection. Clinical features and laboratory findings in nine cases with severe joint symptoms. Ann Rheum Dis (1972) 1.21
Anti-cardiolipin antibodies and risk of myocardial infarction in a prospective cohort of middle-aged men. Circulation (1995) 1.21
Musculoskeletal disorders as determinants of disability in Finns aged 30 years or more. J Clin Epidemiol (1993) 1.20
Finnish case-control and family studies support PTPN22 R620W polymorphism as a risk factor in rheumatoid arthritis, but suggest only minimal or no effect in juvenile idiopathic arthritis. Genes Immun (2005) 1.19
Risk factors for subarachnoid hemorrhage in a longitudinal population study. J Clin Epidemiol (1991) 1.19
Reactive arthritis. Clin Rheum Dis (1985) 1.18
Yersinia enterocolitica infection associated with brucella agglutinins. Clinical features of 24 patients. Acta Med Scand (1969) 1.18
Purification of filaggrin from human epidermis and measurement of antifilaggrin autoantibodies in sera from patients with rheumatoid arthritis by an enzyme-linked immunosorbent assay. Int Arch Allergy Immunol (1998) 1.17
Serological cross-reactions between different Brucella species and Yersinia enterocolitica. Agglutination and complement fixation. Acta Vet Scand (1971) 1.17
Antibody against oxidized low-density lipoprotein predicting myocardial infarction. Arch Intern Med (1994) 1.15
Incidence and prevalence of ankylosing spondylitis in Finland. J Rheumatol (1997) 1.15
Yersinia reactive arthritis. Br J Rheumatol (1983) 1.15
Serum HI antibody and protection against influenza: a follow-up survey at community level of three epidemics caused by different H3N2-variants. Int J Epidemiol (1975) 1.14
Early-onset osteoarthritis linked to the type II procollagen gene. Detailed clinical phenotype and further analyses of the gene. Arthritis Rheum (1993) 1.14
Cerebral vasculitis visualized by angiography in juvenile rheumatoid arthritis simulating brain tumor. Acta Rheumatol Scand (1968) 1.13
Shortening of life span and causes of excess mortality in a population-based series of subjects with rheumatoid arthritis. Clin Exp Rheumatol (1995) 1.13
Enteric infection with Yersinia enterocolitica. Large pyroninophilic cell reaction in mesenteric lymph nodes associated with early production of specific antibodies. Acta Pathol Microbiol Scand A (1971) 1.13
Chemotaxis in yersinia arthritis. In vitro stimulation of neutrophil migration by HLA--B27 positive and negative sera. Arthritis Rheum (1982) 1.12
Association of overweight, trauma and workload with coxarthrosis. A health survey of 7,217 persons. Acta Orthop Scand (1993) 1.12
Incidence of chronic inflammatory joint diseases in Finland in 1995. J Rheumatol (2000) 1.12
Noise and blood-pressure. Lancet (1977) 1.12
Descriptive epidemiology and public health aspects of low back pain. Ann Med (1989) 1.10
Incidence of rheumatoid arthritis in Finland during 1980-1990. Ann Rheum Dis (1996) 1.10
Syphilis, homosexuality and legislation. Dermatologica (1976) 1.09
Seroepidemiology of H1N1 influenza: striking differences in the attack rate among young people. Acta Pathol Microbiol Scand B (1979) 1.09
False-positive serological test for syphilis in pregnancy. Acta Derm Venereol (1969) 1.08
Rheumatoid factor and immuno-conglutinin responses following various vaccinations. Proc Soc Exp Biol Med (1967) 1.08
Studies of syphilitic antibodies. II. Substances responsible for biological false positive sero-reactions. Br J Vener Dis (1968) 1.07
The occurrence of circulating anticoagulants in patients with syphilitic and biologically false positive antilipoidal antibodies. Ann Clin Res (1974) 1.07
[Rheumatoid arthritis shortens life]. Duodecim (1995) 1.07
Association of autoantibodies to filaggrin with an active disease in early rheumatoid arthritis. Ann Rheum Dis (2001) 1.07
Mezlocillin in the treatment of gonorrhoea. Br J Vener Dis (1979) 1.06
Maturation of immunoglobulin G avidity after rubella vaccination studied by an enzyme linked immunosorbent assay (avidity-ELISA) and by haemolysis typing. J Med Virol (1989) 1.06
Measuring rheumatoid factor in nonrheumatoid subjects: immunoturbidimetric assay, latex slide test, and enzyme-linked immunosorbent assay compared. Clin Chem (1991) 1.05
The expression of autoimmune polyglandular disease type I appears associated with several HLA-A antigens but not with HLA-DR. J Clin Endocrinol Metab (1988) 1.04